Cargando…
Cost-effectiveness of anti-SARS-CoV-2 antibody diagnostic tests in Brazil
BACKGROUND: Although serologic tests for COVID-19 diagnosis are rarely indicated nowadays, they remain commercially available and widely used in Brazil. The objective of this study was to evaluate the cost-effectiveness of anti-SARS-CoV-2antibody diagnostic tests for COVID-19 in Brazil. METHODS: Ele...
Autores principales: | de Assis, Tália Santana Machado, Freire, Mariana Lourenço, Carvalho, Janaína de Pina, Rabello, Ana, Cota, Gláucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880880/ https://www.ncbi.nlm.nih.gov/pubmed/35213578 http://dx.doi.org/10.1371/journal.pone.0264159 |
Ejemplares similares
-
Estimating direct costs of the treatment for mucosal leishmaniasis in Brazil
por: Carvalho, Janaína de Pina, et al.
Publicado: (2021) -
Evaluation of a new brand of immunochromatographic test for visceral leishmaniasis in Brazil made available from 2018
por: Freire, Mariana Lourenço, et al.
Publicado: (2018) -
Cost-effectiveness of serological tests for human visceral leishmaniasis in the Brazilian scenario
por: Freire, Mariana Lourenço, et al.
Publicado: (2020) -
Performance of serological tests available in Brazil for the diagnosis of human visceral leishmaniasis
por: Freire, Mariana Lourenço, et al.
Publicado: (2019) -
Intralesional infiltration versus parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: A cost-effectiveness analysis
por: Brito, Nayara C., et al.
Publicado: (2019)